BlackRock’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $526K | Sell |
|
|||||
|
2025
Q1 | $559K | Buy |
|
|||||
|
2024
Q4 | $425K | Buy |
|
|||||
|
2024
Q3 | $511K | Buy |
|
|||||
|
2024
Q2 | $355K | Buy |
|
|||||
|
2024
Q1 | $483K | Sell |
|
|||||
|
2023
Q4 | $608K | Sell |
|
|||||
|
2023
Q3 | $528K | Sell |
|
|||||
|
2023
Q2 | $805K | Buy |
|
|||||
|
2023
Q1 | $1.06M | Sell |
|
|||||
|
2022
Q4 | $1.25M | Sell |
|
|||||
|
2022
Q3 | $1.46M | Buy |
|
|||||
|
2022
Q2 | $311K | Sell |
|
|||||
|
2022
Q1 | $279K | Sell |
|
|||||
|
2021
Q4 | $312K | Sell |
|
|||||
|
2021
Q3 | $525K | Sell |
|
|||||
|
2021
Q2 | $458K | Buy |
|
|||||
|
2021
Q1 | $478K | Buy |
|
|||||
|
2020
Q4 | $289K | Buy |
|
|||||
|
2020
Q3 | $212K | Sell |
|
|||||
|
2020
Q2 | $271K | Buy |
|
|||||
|
2020
Q1 | $128K | Sell |
|
|||||
|
2019
Q4 | $266K | Sell |
|
|||||
|
2019
Q3 | $344K | Buy |
|
|||||
|
2019
Q2 | $289K | Buy |
|
|||||
|
2019
Q1 | $225K | Sell |
|
|||||
|
2018
Q4 | $206K | Buy |
|
|||||
|
2018
Q3 | $242K | Buy |
|
|||||
|
2018
Q2 | $139K | Buy |
|
|||||
|
2018
Q1 | $19K | Hold |
|
|||||
|
2017
Q4 | $11K | Hold |
|
|||||
|
2017
Q3 | $13K | Hold |
|
|||||
|
2017
Q2 | $6K | Hold |
|
|||||
|
2017
Q1 | $14K | Buy |
|